Regulation and signaling of human bombesin receptors and their biological effects

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 16, Issue 1, 2009, Pages 66-71

  Weber, H Christian ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bombesin receptor subtype 3; Gastrin releasing peptide; Mammalian bombesin receptors; Neuromedin B; Receptor regulation and signaling

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ADAM PROTEIN; ANTINEOPLASTIC AGENT; BOMBESIN RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FOCAL ADHESION KINASE; GASTRIN RELEASING PEPTIDE RECEPTOR; GASTRIN RELEASING PEPTIDE RECEPTOR ANTAGONIST; INTERLEUKIN 8; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

CELL ADHESION; CELL METABOLISM; CELL MIGRATION; CELL MOTILITY; COLORECTAL CANCER; GENE CONTROL; GENE LOCUS; GENE MAPPING; GENE OVEREXPRESSION; GENE SILENCING; GENETIC CODE; HUMAN; LUNG CANCER; NONHUMAN; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; UPREGULATION; X CHROMOSOME;

ANIMALS; GASTRIN-RELEASING PEPTIDE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; MALE; MAMMALS; NEOPLASMS; PROSTATIC NEOPLASMS; RECEPTORS, BOMBESIN; SIGNAL TRANSDUCTION;

EID: 58849153281     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32831cf5aa     Document Type: Review

References (86)

1. Jensen RT, Battey JF, Spindel ER, Benya RV. International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 2008; 60:1-42. Outstanding comprehensive review of the pharmacology, biology and nomenclature of mammalian bombesin receptors.
2. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 2007; 448:700-703. Novel function of GRP as an itch-specific mediator. Chronic itch represents a widespread clinical condition.
3. Sakamoto H, Matsuda K, Zuloaga DG, et al. Sexually dimorphic gastrin releasing peptide system in the spinal cord controls male reproductive functions. Nat Neurosci 2008; 11:634-636. This study demonstrates the importance of GRP neurons in the lower spinal cord for penile reflexes.
4. Battey JF, Way JM, Corjay MH, et al. Molecular cloning of the bombesin/ gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci U S A 1991; 88:395-399.
5. Corjay MH, Dobrzanski DJ, Way JM, et al. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J Biol Chem 1991; 266:18771-18779.
6. Spindel ER, Giladi E, Brehm P, et al. Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol Endocrinol 1990; 4:1956-1963.
7. Liu J, Lao ZJ, Zhang J, et al. Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3). Biochemistry 2002; 41:8954-8960.
8. Wada E, Way J, Shapira H, et al. cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor. Neuron 1991; 6:421-430.
9. Ohki-Hamazaki H, Watase K, Yamamoto K, et al. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 1997; 390:165-169.
10. Weber HC, Hampton LL, Jensen RT, Battey JF. Structure and chromosomal localization of the mouse bombesin receptor subtype 3 gene. Gene 1998; 211:125-131.
11. Weber HC, Jensen RT, Battey JF. Molecular organization of the mouse gastrin-releasing peptide receptor gene and its promoter. Gene 2000; 244:137-149.
12. Xiao D, Wang J, Hampton LL, Weber HC. The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. Gene 2001; 264:95-103.
13. Gorbulev V, Akhundova A, Grzeschik KH, Fahrenholz F. Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus. FEBS Lett 1994; 340:260-264.
14. Maslen GL, Boyd Y. Comparative mapping of the Grpr locus on the X chromosomes of man and mouse. Genomics 1993; 17:106-109.
15. Qu X, Xiao D, Weber HC. Transcriptional activation of the human gastrin-releasing peptide receptor gene in gastrointestinal and prostatic epithelial cancer cells. J Mol Neurosci 2004; 22:75-82.
16. Qiao J, Cree J, Kang J, et al. Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas. Surgery 2004; 136:489-494.
17. Chinnappan D, Qu X, Xiao D, et al. Human gastrin-releasing peptide receptor gene regulation requires transcription factor binding at two distinct CRE sites. Am J Physiol Gastrointest Liver Physiol 2008; 295:G153-G162. This is the first report to delineate the regulation of the human GRP-R gene by cAMP-dependent signaling pathways. Transcription factors CREB and ATF-1 bind to the human GRP-R promoter and upregulate expression.
18. Shumyatsky GP, Tsvetkov E, Malleret G, et al. Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell 2002; 111:905-918.
19. Roesler R, Kapczinski F, Quevedo J, et al. The gastrin-releasing peptide receptor as a therapeutic target in central nervous system disorders. Recent Patents CNS Drug Discov 2007; 2:125-129.
20. Roesler R, Luft T, Oliveira SH, et al. Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus. Neuropharmacology 2006; 51:350-357.
21. Presti-Torres J, de Lima MN, Scalco FS, et al. Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: Implications for an animal model of neurodevelopmental disorders. Neuropharmacology 2007; 52:724-732.
22. Aida R, Moriya T, Araki M, et al. Gastrin-releasing peptide mediates photic entrainable signals to dorsal subsets of suprachiasmatic nucleus via induction of period gene in mice. Mol Pharmacol 2002; 61:26-34.
23. Karatsoreos IN, Romeo RD, McEwen BS, Silver R. Diurnal regulation of the gastrin-releasing peptide receptor in the mouse circadian clock. Eur J Neurosci 2006; 23:1047-1053.
24. McArthur AJ, Coogan AN, Ajpru S, et al. Gastrin-releasing peptide phase-shifts suprachiasmatic nuclei neuronal rhythms in vitro. J Neurosci 2000; 20:5496-5502.
25. Mai LM, Pan JT. Bombesin acts in the suprachiasmatic nucleus to affect circadian changes in tuberoinfundibular dopaminergic neuron activity and prolactin secretion. Endocrinology 1995; 136:4163-4167.
26. Nakamichi Y, Wada E, Aoki K, et al. Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice. Biochem Biophys Res Commun 2004; 318:698-703.
27. Maekawa F, Quah HM, Tanaka K, Ohki-Hamazaki H. Leptin resistance and enhancement of feeding facilitation by melanin-concentrating hormone in mice lacking bombesin receptor subtype-3. Diabetes 2004; 53:570-576.
28. Tan YR, Qi MM, Qin XQ, et al. Wound repair and proliferation of bronchial epithelial cells enhanced by bombesin receptor subtype 3 activation. Peptides 2006; 27:1852-1858.
29. Tan YR, Qin XQ, Xiang Y, et al. PPARalpha and AP-2alpha regulate bombesin receptor subtype 3 expression in ozone-stressed bronchial epithelial cells. Biochem J 2007; 405:131-137. This study examines the regulation of the human BRS-3 gene in bronchial epithelial cells and demonstrates binding of transcription factors PPAR alpha and AP-2 alpha to the promoter and hBRS-3 upregulation.
30. Wang Y, Zhang M, Tan Y, et al. BRS-3 activation transforms the effect of human bronchial epithelial cells from PGE2 mediated inhibition to TGF-beta1 dependent promotion on proliferation and collagen synthesis of lung fibroblasts. Cell Biol Int 2007; 31:1495-1500.
31. Gonzalez N, Moody TW, Igarashi H, et al. Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 2008; 15:58-64.
32. Subramaniam M, Bausch C, Twomey A, et al. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2007; 176:902-912.
33. Ashour K, Shan L, Lee JH, et al. Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice. Am J Respir Crit Care Med 2006; 173:1377-1385.
34. Ganter MT, Pittet JF. Bombesin-like peptides: modulators of inflammation in acute lung injury? Am J Respir Crit Care Med 2006; 173:1-2.
35. Rosen D, Lee JH, Cuttitta F, et al. Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2006; 174:75-83.
36. Dal-Pizzol F, Di Leone LP, Ritter C, et al. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am J Respir Crit Care Med 2006; 173:84-90.
37. Ladenheim EE, Behles RR, Bi S, Moran TH. Gastrin-releasing peptide mRNA expression in the hypothalamic paraventricular nucleus is altered by melanocortin receptor stimulation and food deprivation. Endocrinology 2008 [Epub ahead of print).
38. Ladenheim EE, Knipp S. Capsaicin treatment differentially affects feeding suppression by bombesin-like peptides. Physiol Behav 2007; 91:36-41.
39. Ladenheim EE, Hamilton NL, Behles RR, et al. Factors contributing to obesity in bombesin receptor subtype-3-deficient mice. Endocrinology 2008; 149:971-978.
40. Hoggard N, Bashir S, Cruickshank M, et al. Expression of neuromedin B in adipose tissue and its regulation by changes in energy balance. J Mol Endocrinol 2007; 39:199-210.
41. Baroni A, Perfetto B, Canozo N, et al. Bombesin: a possible role in wound repair. Peptides 2008; 29:1157-1166.
42. Sukhotnik I, Slijper N, Karry R, et al. Bombesin stimulates enterocyte turnover following massive small bowel resection in a rat. Pediatr Surg Int 2007; 23:397-404.
43. Lu L, Shimizu T, Nakamura K, Yokotani K. Brain neuronal/inducible nitric oxide synthases and cyclooxygenase-1 are involved in the bombesin-induced activation of central adrenomedullary outflow in rats. Eur J Pharmacol 2008; 590:177-184.
44. Grimsholm O, Rantapaa-Dahlqvist S, Dalen T, Forsgren S. Observations favouring the occurrence of local production and marked effects of bombesin/ gastrin-releasing peptide in the synovial tissue of the human knee joint-comparisons with substance P and the NK-1 receptor. Neuropeptides 2008; 42:133-145.
45. Oliveira PG, Brenol CV, Edelweiss MI, et al. Effects of an antagonist of the bombesin/gastrin-releasing peptide receptor on complete Freund's adjuvant-induced arthritis in rats. Peptides 2008; 29:1726-1731.
46. Petronilho F, Roesler R, Schwartsmann G, Dal Pizzol F. Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases. Inflamm Allergy Drug Targets 2007; 6:197-200.
47. Grimsholm O, Guo Y, Ny T, et al. Are neuropeptides important in arthritis? Studies on the importance of bombesin/GRP and substance P in a murine arthritis model. Ann N Y Acad Sci 2007; 1110:525-538.
48. Bedard T, Mountney C, Kent P, et al. Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior. Behav Brain Res 2007; 179:133-140.
49. Luft T, Amaral OB, Schwartsmann G, Roesler R. Transient disruption of fear-related memory by postretrieval inactivation of gastrin-releasing Peptide or N-methyl-d-aspartate receptors in the hippocampus. Curr Neurovasc Res 2008; 5:21-27.
50. Preissler T, Luft T, Kapczinski F, et al. Basic fibroblast growth factor prevents the memory impairment induced by gastrin-releasing peptide receptor antagonism in area CA1 of the rat hippocampus. Neurochem Res 2007; 32:1381-1386.
51. Oliveira KJ, Cabanelas A, Veiga MA, et al. Impaired serum thyrotropin response to hypothyroidism in mice with disruption of neuromedin B receptor. Regul Pept 2008; 146:213-217.
52. Cornelio DB, Roesler R, Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol 2007; 18:1457-1466.
53. Patel O, Shulkes A, Baldwin GS. Gastrin-releasing peptide and cancer. Biochim Biophys Acta 2006; 1766:23-41.
54. Qu X, Xiao D, Weber HC. Biologic relevance of mammalian bombesin-like peptides and their receptors in human malignancies. Curr Opin Endocrinol Diab 2003; 10:60-71.
55. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 2007; 213:589-602.
56. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26:3291-3310.
57. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008; 358:1160-1174.
58. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008; 9:517-531.
59. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999; 402:884-888.
60. Xiao D, Qu X, Weber HC. Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells. Cell Signal 2003; 15:945-953.
61. Lui VW, Thomas SM, Zhang Q, et al. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. Oncogene 2003; 22:6183-6193.
62. Thomas SM, Grandis JR, Wentzel AL, et al. Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells. Neoplasia 2005; 7:426-431.
63. Bhola NE, Grandis JR. Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer. Front Biosci 2008; 13:1857-1865.
64. Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005; 6:32-43.
65. Fischer OM, Hart S, Gschwind A, Ullrich A. EGFR signal transactivation in cancer cells. Biochem Soc Trans 2003; 31:1203-1208.
66. Ohtsu H, Dempsey PJ, Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 2006; 291:C1-10.
67. Liu X, Carlisle DL, Swick MC, et al. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib. Exp Cell Res 2007; 313:1361-1372. This study shows that PI3 kinase is downstream target of EGF-R transactivation.
68. Zhang Q, Bhola NE, Lui VW, et al. Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer. Mol Cancer Ther 2007; 6:1414-1424. Important study to show that a combination of GRP-R and EGF-R inhibition results in enhanced tumor cell blockade.
69. Flores DG, de Farias CB, Leites J, et al. Gastrin-releasing peptide receptors regulate proliferation of C6 glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism. Curr Neurovasc Res 2008; 5:99-105.
70. Ishola TA, Kang J, Qiao J, et al. Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells. Biochim Biophys Acta 2007; 1770:927-932.
71. Qiao J, Kang J, Ishola TA, et al. Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma. Proc Natl Acad Sci U S A 2008; 105:12891-12896.
72. Farias CB, Lima RC, Lima LO, et al. Stimulation of proliferation of U138-MG glioblastoma cells by gastrin-releasing peptide in combination with agents that enhance cAMP signaling. Oncology 2008; 75:27-31.
73. Qu X, Xiao D, Weber HC. Human gastrin-releasing peptide receptor mediates sustained CREB phosphorylation and transactivation in HuTu 80 duodenal cancer cells. FEBS Lett 2002; 527:109-113.
74. Jensen JA, Carroll RE, Benya RV. The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer. Peptides 2001; 22:689-699.
75. Taglia L, Matusiak D, Matkowskyj KA, Benya RV. Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase. Am J Physiol Gastrointest Liver Physiol 2007; 292:G182-G190.
76. Zheng R, Iwase A, Shen R, et al. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase. Oncogene 2006; 25:5942-5952.
77. Corral RS, Iniguez MA, Duque J, et al. Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells. Oncogene 2007; 26:958-969. Novel mechanism by which bombesin targets COX-2 and mediates cell migration.
78. Guo YS, Chen Z, Wen XD, et al. Synergistic regulation of COX-2 expression by bombesin and transforming growth factor-beta. Dig Dis Sci 2008; 53:2045-2052.
79. Kang J, Ishola TA, Baregamian N, et al. Bombesin induces angiogenesis and neuroblastoma growth. Cancer Lett 2007; 253:273-281.
80. Kanashiro CA, Schally AV, Zarandi M, et al. Alterations of EGFR/HER, angiogenesis and apoptosis pathways after therapy with antagonists of growth hormone releasing hormone and bombesin in nonsmall cell lung cancer. Int J Oncol 2007; 30:1019-1028.
81. Fleischmann A, Waser B, Reubi JC. Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms. Cell Oncol 2007; 29:421-433. This study shows strong GRP-R expression in tumor vessels suggesting an important function for GRP in angiogenesis.
82. Desai SJ, Ma AH, Tepper CG, et al. Inappropriate activation of the androgen receptor by nonsteroids: involvement of the Src kinase pathway and its therapeutic implications. Cancer Res 2006; 66:10449-10459.
83. Lee LF, Guan J, Qiu Y, Kung HJ. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol 2001; 21:8385-8397.
84. Lee JG, Ge R, Hardy DO, et al. Modulation of 11 beta-Hydroxysteroid dehydrogenase expression by bombesin: a possible mechanism for glucocorticoid resistance in androgen independent prostate cancer. Horm Metab Res 2008; 40:772-778.
85. Xiao D, Chinnappan D, Pestell R, et al. Bombesin regulates cyctin D1 expression through the early growth response protein Egr-1 in prostate cancer cells. Cancer Res 2005; 65:9934-9942.
86. Salah Z, Maoz M, Pizov G, Bar-Shavit R. Transcriptional regulation of human protease-activated receptor 1 : a role for the early growth response-1 protein in prostate cancer. Cancer Res 2007; 67:9835-9843. Bombesin-dependent Egr-1 activation has multiple downstream targets in prostate cancer.